Tetrabenazine D6 - CAS# 1392826-25-3 pine D8 fumarate Smiles: CC1C(=CC=C(C#N)C=1Cl)N1[C@H]2CC(C)(O)C[C@H]1CC2

Smiles: CC1C(=CC=C(C#N)C=1Cl)N1[C@H]2CC(C)(O)C[C@H]1CC2

InChi: InChI=1S/C25H27ClN6O3/c1-4-23(33)28-17-6-5-7-19(14-17)35-24-20(26)16-27-25(30-24)29-21-9-8-18(15-22(21)34-3)32-12-10-31(2)11-13-32/h4-9

in both species

194423-06-8

InChi: InChI=1S/C20H21N3O7S/c1-4-28-20(25)30-13(2)29-18-14-9-5-6-10-15(14)31(26

Tetrabenazine D6 - CAS# 1392826-25-3 pine D8 fumarate Smiles: CC1C(=CC=C(C#N)C=1Cl)N1[C@H]2CC(C)(O)C[C@H]1CC2Deutetrabenazine, also known as SD 809 and Tetrabenazine d6, is an investigational, oral, small molecule inhibitor of vesicular monoamine 2 transporter, or VMAT2, that is designed to regulate the levels of a specific neurotransmitter, dopamine, in the brain. Deutetrabenazine is a deuterated tetrabenazine. SD 809 is being developed for the treatment of chorea associated with Huntingtons disease, a neurodegenerative movement disorder that impacts